SL Investment is a venture capital firm based in Seoul, South Korea, established in February 2000. The firm focuses on investing in small and medium-sized companies across various sectors, including biotechnology, healthcare, semiconductors, display technologies, renewable energy, and artificial intelligence. SL Investment has a strong track record, having achieved positive financial results for 12 consecutive years without incurring any debt. The firm not only provides capital but also actively supports the management of its portfolio companies to enhance their value. Over the years, SL Investment has successfully facilitated the listing of 31 companies on the KOSDAQ market, helping them to become leaders in their respective industries.
AIRS Medical Co., Ltd. is a South Korean company focused on developing and marketing artificial intelligence-based software for magnetic resonance imaging (MRI). The company's flagship product, SwiftMR, enhances MRI images by utilizing advanced algorithms, including parallel imaging and deep learning, to improve scan speed and image quality. This software not only suggests optimal scanning parameters but also reconstructs images without introducing additional artifacts, thus minimizing motion and hardware-related imperfections. In addition to image reconstruction, AIRS Medical provides tools for assessing image quality and visualizing unseen artifacts, ultimately aiming to improve patient outcomes and streamline institutional efficiency in healthcare settings.
AIRS
Series A in 2025
AIRS is at the forefront of advancing orthopedic surgery, setting the stage for the future with its innovative surgical platforms. The company is preparing for the next era in surgical technology, known as SURGERY 4.0. By leading the way with cutting-edge solutions, AIRS aims to transform orthopedic procedures, enhance precision, and redefine standards in surgical care.
Soomvi
Venture Round in 2024
Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving systems. The firm develops advanced drones equipped with technology that enables them to recognize and learn from their environment, ensuring enhanced security and operational performance. These drones feature a sensor-isolated and vibration-resistant design, which contributes to their reliability in various applications. Soomvi's drones also offer real-time synchronization and communication capabilities, allowing for effective monitoring of flight information and backup control system operations. This technology positions Soomvi as a key player in providing innovative solutions for industrial needs, particularly in maritime safety.
Aldavar
Series A in 2024
ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.
Panmnesia
Series A in 2024
Panmnesia, a South Korean startup, specializes in the development of intellectual property for a proprietary technology called Compute Express Link. This technology enables large data center operators to pool and efficiently manage resources like AI accelerator chips, processors, and memory, enhancing system performance and flexibility.
Novelty Nobility
Series C in 2024
Novelty Nobility Inc. is a private biotechnology company dedicated to researching novel angiogenesis targets to develop antibody-based therapeutics for ophthalmology and oncology. The company has identified a significant target, Stem Cell Factor (SCF) and its receptor c-KIT, which are crucial in the proliferation and survival of hematopoietic stem cells. This discovery aims to address the limitations of existing anti-VEGF treatments, particularly in terms of efficacy and long-term safety. The company's lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development. Novelty Nobility's research is strongly patent-protected in the United States and South Korea, positioning it to provide innovative therapeutic options for diseases associated with abnormal blood vessel growth, such as certain retinal conditions and solid tumors.
EMCRAFTS
Convertible Note in 2024
EMCRAFTS specializes in the manufacturing and designing of scanning electron microscopes.
LINER
Series B in 2024
LINER is a pioneering company in the field of artificial intelligence, specifically focusing on enhancing productivity through its AI-powered search engine. Known as Asia's first AI agent, LINER's platform utilizes large language model technology to perform a variety of complex tasks, streamlining the research process for users. Its unique highlighter database allows for efficient information management, significantly reducing research time from hundreds of minutes to mere seconds. Serving a global user base, with over 94% of its clientele located outside Korea, LINER operates in more than 100 countries. The company aims to help users collect and develop insights more effectively, thereby improving overall productivity.
Trenbe
Series E in 2024
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.
MedInTech
Series B in 2024
MedInTech specializes in developing advanced medical devices, specifically smart endoscopes designed for the digestive system. The company's innovative motorized endoscopy device offers a user-friendly control mechanism, featuring a lightweight and comfortable handle that enhances surgical precision. By integrating artificial intelligence, the device aids in lesion detection and classification, thereby helping surgeons reduce the risk of misdiagnosis and improve patient safety. MedInTech's focus on intuitive design and autonomous control positions it as a key player in the field of medical technology.
Creative MUT
Series A in 2024
Creative MUT is a media solutions company that specializes in content planning, production, BX, and VFX creations.
Edgecare
Series A in 2023
Edgecare is a manufacturing company that specializes in developing medical devices. These include precision and optical devices designed to enhance healthcare quality and affordability. The company's portfolio includes bladder image scanners for urinary diagnosis, enabling early disease detection and treatment.
Mardi Mercredi
Series A in 2023
Mardi Mercredi is a clothing store that specializes in providing easy-to-wear everyday apparel for women, men, and children. The product range includes jackets, jeans, tops, shirts, and various accessories, all designed to meet the diverse needs of customers. The company focuses on offering French-inspired fashionable and designer clothing, ensuring that shoppers have access to stylish options that suit their preferences.
Panmnesia
Seed Round in 2023
Panmnesia, a South Korean startup, specializes in the development of intellectual property for a proprietary technology called Compute Express Link. This technology enables large data center operators to pool and efficiently manage resources like AI accelerator chips, processors, and memory, enhancing system performance and flexibility.
AB180
Series B in 2023
AB180 is a performance marketing firm that leverages data analytics and marketing technology to support organizations in navigating the digital landscape. The company has developed a marketing platform that enables businesses to gain insights into customer behavior by collecting and processing real-time data from mobile users. This approach helps businesses better understand their customers and enhances their marketing effectiveness, ultimately leading to improved results.
Solvook
Series A in 2023
Solvook is a copyright licensing platform focused on educational materials, offering services that facilitate copyright clearance. The platform features a cloud-based library that houses a variety of digital educational resources, allowing users to conveniently access a comprehensive database of knowledge. By streamlining the copyright licensing process, Solvook aims to support educators and institutions in navigating the complexities of copyright compliance while enhancing access to valuable educational content.
Best Graphene
Series A in 2023
Best Graphene specializes in the manufacturing of graphene products tailored for a wide range of industrial sectors. Best Graphene provides a diverse array of products to cater to various needs, such as graphene colloid, graphene ink and paste, additive graphene, and customizable graphene solutions. These offerings ensure optimal process suitability and compatibility across different materials, empowering users to harness the unique properties of graphene for enhanced performance and applications in their respective industries.
NextQure
Seed Round in 2023
NextQure is an electronic medicine company focused on expanding the transcranial magnetic stimulation (TMS) market and facilitating home treatment solutions. The company develops a range of products designed to improve patient care and health outcomes. Among its offerings is emqure, which enhances language memory and cognitive function, and emfree, which provides treatment for depression. Additionally, NextQure's pipeline includes therapies for intractable diseases, addiction, and sleep disorders, enabling patients to access effective treatments from the comfort of their homes.
Youniv
Venture Round in 2023
Youniv is a digital media platform based in Korea, tailored specifically for university students, particularly those from Generation Z. The company focuses on producing video content that resonates with the student demographic, addressing their unique needs and interests. By creating relevant and engaging material, Youniv aims to enhance students' knowledge and foster a sense of connection among them. The platform serves as a valuable resource for students seeking to navigate their academic and social environments, ultimately enriching their university experience.
GrowV
Series A in 2023
growV is an educational service provider that leverages learning technology to foster a valuable educational culture. The company has developed a platform that delivers customized educational content in subjects such as English, mathematics, and Korean. This content is specifically designed for young children and is accessible through a dedicated tablet. By focusing on early education, growV aims to empower children to learn, grow, and realize their aspirations.
Onconic Therapeutics
Series B in 2022
Onconic Therapeutics is dedicated to the research and development of innovative cancer treatments. The company focuses on creating next-generation anti-cancer therapies that target the mechanisms involved in cancer cell growth and DNA damage repair. By simultaneously suppressing key signal delivery agents and repair enzymes, Onconic aims to provide healthcare professionals with effective therapeutic options for treating various cancers.
People & Technology
Series B in 2022
People & Technology specializes in providing digital transformation-based artificial intelligence solutions focused on indoor geolocation and smart sensing. Their IndoorPlus+ platform, which includes Location Based Systems (LBS) and Real Time Location Systems (RTLS), serves various industries such as healthcare, manufacturing, defense, smart cities, and the public sector. The company has established a robust client base of over 100 corporate customers across sectors like banking, retail, energy, and public services, offering solutions that enhance employee safety, asset tracking, security and access control, and process efficiency. By implementing these industry-grade systems, clients have experienced increased productivity, improved operational processes, and mitigated corporate risks. Founded in 2013, People & Technology has emerged as a leading provider in South Korea and is actively expanding its presence in international markets.
Aurumplanet
Series B in 2022
Aurumplanet (아우름플래닛) is a Korean online platform that provides IT-related information. It was launched in September 2012 in Seoul, Korea.
Trenbe
Series D in 2022
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.
LINER
Series B in 2022
LINER is a pioneering company in the field of artificial intelligence, specifically focusing on enhancing productivity through its AI-powered search engine. Known as Asia's first AI agent, LINER's platform utilizes large language model technology to perform a variety of complex tasks, streamlining the research process for users. Its unique highlighter database allows for efficient information management, significantly reducing research time from hundreds of minutes to mere seconds. Serving a global user base, with over 94% of its clientele located outside Korea, LINER operates in more than 100 countries. The company aims to help users collect and develop insights more effectively, thereby improving overall productivity.
Novelty Nobility
Series B in 2022
Novelty Nobility Inc. is a private biotechnology company dedicated to researching novel angiogenesis targets to develop antibody-based therapeutics for ophthalmology and oncology. The company has identified a significant target, Stem Cell Factor (SCF) and its receptor c-KIT, which are crucial in the proliferation and survival of hematopoietic stem cells. This discovery aims to address the limitations of existing anti-VEGF treatments, particularly in terms of efficacy and long-term safety. The company's lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development. Novelty Nobility's research is strongly patent-protected in the United States and South Korea, positioning it to provide innovative therapeutic options for diseases associated with abnormal blood vessel growth, such as certain retinal conditions and solid tumors.
Zenerate
Seed Round in 2022
Zenerate Inc. specializes in providing AI-driven building design solutions aimed at optimizing real estate development. Founded in 2020 and based in Seoul, South Korea, the company utilizes an advanced artificial intelligence platform that takes into account various factors such as project objectives, rental and construction costs. By employing algorithms, Zenerate generates a range of design alternatives, streamlining the planning process for architects, urban planners, and designers. This technology not only enhances efficiency but also automates tasks that were traditionally performed manually, enabling quicker decision-making in the design phase of construction projects.
D'Cent
Series A in 2021
D'Cent specializes in providing cryptocurrency hardware wallets designed to secure digital assets. The company offers a range of embedded security services aimed at protecting customers' virtual currencies. Its products include digital asset cold storage, secure private key storage, and transaction execution solutions, which combine both software and hardware security measures. By focusing on secure connectivity solutions, D'Cent ensures that customers can confidently manage and safeguard their digital assets.
Greenergy
Series A in 2021
Greenergy designs and manufactures lithium-ion rechargeable batteries through Greenergy's technology.
UrbanPlay
Series A in 2021
UrbanPlay Inc. is a South Korean company established in 2013 that focuses on creating content related to urban culture. It collects and processes both tangible and intangible content, providing a platform for users to explore urban issues in innovative ways. The company offers a variety of services including online platforms, regional projects, multimedia, publications, and community spaces, all aimed at fostering a sustainable urban cultural ecosystem. UrbanPlay designs emotional city experiences by addressing urban challenges through accessible technology, while also providing real estate content services that include local marketing, merchandise, and publishing. This approach enables users to engage with their neighborhoods in a content-oriented manner.
N.thing
Series B in 2021
N.THING, based in Ansan-si, South Korea, is an Agri-Food tech company founded in January 2014 that innovates within the farm-to-table food value chain by integrating IoT technology and data. The company is known for developing the world’s first modular vertical farm, called the CUBE, which offers mass productivity and an optimized environment for various crops through a dedicated operating system. N.THING also offers additional products such as SQUARE, a modular hydroponic kit, and Planty, the first Internet-connected social pot, which enhances the gardening experience by allowing users to monitor environmental conditions and share their plant care activities. With a focus on connecting people to nature and leveraging technology for efficient farming, N.THING has received notable awards, including the iF Design Award and Best of Innovation at CES 2020. The company is expanding its operations globally, aiming to enhance its presence in markets such as North America and the U.A.E.
Neurive
Seed Round in 2021
NEURIVE is a medical research and development company focused on creating electronic and digital medicines. It specializes in the development of digital therapeutics and wearable devices, including non-invasive vagus nerve stimulation devices. These innovations aim to transform the treatment landscape by enabling healthcare providers to offer effective solutions for various conditions, including degenerative brain diseases like dementia, cognitive dysfunction, depression, and tinnitus. Through its advanced therapeutic systems, NEURIVE seeks to enhance patient care and deliver impactful medical resolutions.
SeaWith
Series A in 2021
Seawith is a biotechnology startup focused on producing cell-cultured steak derived from seaweed. The company has developed Yo.od, a low-iodine seaweed designed for consumers who have low iodine resistance and high iodine sensitivity. Seawith utilizes its own culture media made from microalgae, which not only enhances the nutritional profile but is also more cost-effective due to the plentiful availability of microalgae. By creating clean meat in a laboratory setting, Seawith aims to eliminate the need for raising and slaughtering livestock, delivering a product that mimics traditional meat in taste and texture while being both delicious and affordable.
Sir.Loin
Series B in 2021
Sir.Loin is an e-commerce platform specializing in Korean beef, providing customers with direct access to high-quality meat products. The company oversees the entire supply chain, including feeding, breeding, aging, and processing, ensuring that customers receive premium meat without complications. By managing this comprehensive process, Sir.Loin focuses on delivering a seamless customer experience while maintaining high standards of quality in its offerings.
WHYNOT Media
Series C in 2021
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and offering a diverse range of entertainment content, including web series, short films, and web dramas. Notable titles produced by WHYNOT Media include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." The company excels in creating content that resonates with various cultural backgrounds, often through branded content and transmedia storytelling. By emphasizing short-form drama and versatile content franchises, WHYNOT Media aims to provide easily accessible entertainment for its audience.
Cenyx Biotech
Series A in 2021
Cenyx Biotech is focused on advancing healthcare through its innovative platform that utilizes diagnostic and therapeutic nano-compounds based on nanozymes and nanoparticles. The company is developing a unique nano-biotech agent designed to simultaneously eliminate superoxide, hydrogen peroxide, and hydroxyl radicals. This approach aims to help patients and healthcare practitioners manage excessive inflammatory reactions, particularly in the early stages of subarachnoid hemorrhage. By addressing these critical factors, Cenyx Biotech seeks to transform treatment options and improve patient outcomes in the healthcare sector.
HOWSER
Series B in 2021
HOWSER provides furniture construction and delivery solutions through an online infrastructure based on IT technology.
Nexel
Series B in 2021
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.
MitoImmune Therapeutics
Series B in 2021
Mitoimmune Therapeutics is a biotechnology company focused on drug research and development aimed at addressing mitochondrial dysfunction and related cellular disorders. The company is dedicated to creating treatments for diseases associated with mitochondrial dysfunction, including those that are necrotic and inflammatory in nature. Through its innovative approach, Mitoimmune Therapeutics seeks to enhance the quality of life for patients by providing effective therapeutic solutions for complex health issues linked to mitochondrial health.
Biobab AiBIO
Series A in 2021
Biobab AiBIO is a biotechnology company focused on drug development through the integration of artificial intelligence. It specializes in creating innovative technologies for efficient drug discovery, particularly aimed at addressing intractable and rare diseases. The company has developed bio-space voyager technology that enhances the capabilities of traditional X-ray crystallography by employing cryogenic electron microscopy (cryo-EM). This advanced approach allows for the detailed analysis of the three-dimensional structure of new target proteins, facilitating the identification and development of novel drugs for unique therapeutic targets.
everyone's kitchen
Series A in 2021
everyone's kitchen helps in lowering the high cost burden for starting a business.
ImmunoMet Therapeutics
Venture Round in 2021
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, that develops and commercializes innovative oncology drugs aimed at enhancing the quality of life for cancer patients. Founded in 2015, the company focuses on creating metabolic regulators that target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors designed to modulate anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet is committed to advancing its comprehensive pipeline to address the challenges faced by patients with resistant forms of cancer.
B:eat Corp
Series A in 2021
B: eat is a retail automation platform intended to run a robot-based cafe.
Agreable
Series B in 2020
Agreable is a brand commerce startup that manufactures and distributes lifestyle products.
Lab n People
Series B in 2020
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.
Aurumplanet
Series A in 2020
Aurumplanet (아우름플래닛) is a Korean online platform that provides IT-related information. It was launched in September 2012 in Seoul, Korea.
LINER
Series A in 2020
LINER is a pioneering company in the field of artificial intelligence, specifically focusing on enhancing productivity through its AI-powered search engine. Known as Asia's first AI agent, LINER's platform utilizes large language model technology to perform a variety of complex tasks, streamlining the research process for users. Its unique highlighter database allows for efficient information management, significantly reducing research time from hundreds of minutes to mere seconds. Serving a global user base, with over 94% of its clientele located outside Korea, LINER operates in more than 100 countries. The company aims to help users collect and develop insights more effectively, thereby improving overall productivity.
SN BioScience
Series B in 2020
SN BioScience specializes in nano-formulation screening services aimed at enhancing the delivery of small molecules, oligonucleotides, peptides, and proteins. Utilizing their proprietary double core-shell technology, the company develops advanced drug delivery systems, particularly for cancer therapeutics, that facilitate the creation of stable nano-sized micelles, nanoparticles, and liposomes. By providing a diverse array of acceptable lipids and polymers, SN BioScience addresses challenges related to solubility and effective drug delivery, offering significant opportunities for clients working with poorly soluble drugs and innovative oncology products.
INITECH
Seed Round in 2019
INITECH, established in 1997 and headquartered in Seoul, South Korea, is a leading IT security and financial services company. It specializes in developing and implementing robust e-banking systems, including service planning, development, and maintenance, as well as internet and smart banking solutions. INITECH operates data centers offering supplementary services for enterprises and provides a range of IT professional services, such as security system management, consulting, and training programs. The company's portfolio includes the IB20 and UBiz30 frameworks, designed to enhance productivity and adapt to changing business environments. INITECH also offers comprehensive security solutions, including PKI, biometric authentication, ISoT, IAM, system and DB security, end-point security, and hardware security modules. As a subsidiary of H&C Network Co. Ltd., INITECH is committed to creating a safer, more convenient digital world for its clients.
UrbanPlay
Series A in 2019
UrbanPlay Inc. is a South Korean company established in 2013 that focuses on creating content related to urban culture. It collects and processes both tangible and intangible content, providing a platform for users to explore urban issues in innovative ways. The company offers a variety of services including online platforms, regional projects, multimedia, publications, and community spaces, all aimed at fostering a sustainable urban cultural ecosystem. UrbanPlay designs emotional city experiences by addressing urban challenges through accessible technology, while also providing real estate content services that include local marketing, merchandise, and publishing. This approach enables users to engage with their neighborhoods in a content-oriented manner.
WHYNOT Media
Series B in 2019
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and offering a diverse range of entertainment content, including web series, short films, and web dramas. Notable titles produced by WHYNOT Media include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." The company excels in creating content that resonates with various cultural backgrounds, often through branded content and transmedia storytelling. By emphasizing short-form drama and versatile content franchises, WHYNOT Media aims to provide easily accessible entertainment for its audience.
Lab n People
Seed Round in 2019
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.
MitoImmune Therapeutics
Series A in 2019
Mitoimmune Therapeutics is a biotechnology company focused on drug research and development aimed at addressing mitochondrial dysfunction and related cellular disorders. The company is dedicated to creating treatments for diseases associated with mitochondrial dysfunction, including those that are necrotic and inflammatory in nature. Through its innovative approach, Mitoimmune Therapeutics seeks to enhance the quality of life for patients by providing effective therapeutic solutions for complex health issues linked to mitochondrial health.
SOS Lab
Series A in 2018
SOS Lab is a company specializing in the development and manufacturing of LiDAR technology, which utilizes lasers to measure distances and shapes in the surrounding environment. The company focuses on creating innovative solutions for self-driving vehicles, featuring its hybrid LiDAR system, the SL-1, which merges motor scanning systems with solid-state MEMS mirrors. This system aims to reduce costs and enhance accessibility in the autonomous vehicle market. In addition to the SL-1, SOS Lab offers the GL-3 for factory automation and robotics, and the TL-3 for security applications. The company is also advancing its technology by integrating hardware sensors with AI-based object recognition, leveraging 3D point cloud data for improved tracking and recognition. To further its mission, SOS Lab collaborates with partners in the automotive electronics sector and global semiconductor companies, with R&D centers in Seoul and Gwangju and business operations in Silicon Valley to expand its presence in the global self-driving and advanced driver-assistance systems markets.
Fresh Easy
Series A in 2018
Fresh Easy is a distributor of meal kits.
JLK
Venture Round in 2018
JLK, Inc. is a South Korean company that specializes in AI-driven solutions for medical diagnosis and security. The firm develops an artificial intelligence medical analysis platform that provides on-site and real-time services connected to various hospital systems, addressing the diagnostic needs of healthcare professionals. JLK's offerings encompass medical management, treatment, and services related to brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease, as well as conditions affecting the lungs, coronary artery disease, prostate cancer, and digital pathology. Headquartered in Cheongju, South Korea, JLK aims to enhance healthcare delivery through its advanced technological solutions.
Caret Games
Venture Round in 2018
Caret Games is a company specialized in developing mobile games with over 50 employees based on South Korea. The company consists of talented developers and they are developing games with passion. Caret Games developed Full3D mobile MMORPG ‘RebirthM’ in the end of 2017. The company is trying to make a game which many people can enjoy and play for a long time, and the first is ‘RebirthM’. Caret Games services 'RebirthM' directly in South Korea and is currently preparing for global service. About "Rebirth M"! The game also known as Rebirth: Shadow of Salvation, is a mobile MMORPG that’s supposed to rival PC MMORPGs. Made with Unity3D, the game boasts high graphics and PC-like gameplay experience. Now that it’s been more than a year since its announcement in South Korea, the game is finally out in Brazil which a global release will follow suit later.
Urbanbase
Series A in 2017
Urbanbase Inc. is a design platform based in Seoul, South Korea, that specializes in transforming two-dimensional floor plans into three-dimensional models. Founded in 2014, the company has developed patented technology that enables the rapid conversion of 2D designs into 3D, augmented reality (AR), and virtual reality (VR) formats. Urbanbase offers a consumer-facing VR home furnishing platform and an AR mobile application, enhancing the interior design experience. Additionally, it provides a business-to-business sales tool utilizing its proprietary 3D, AR, and VR APIs, catering to various sectors including real estate, home design, and retail. The company serves a diverse clientele, including notable brands like LG, iLoom, and Daelim, as well as over 40 other interior and furniture companies.
Wantedlab
Series B in 2017
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer job applicants to companies and earn rewards when those applicants are hired. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, all of which utilize Wanted to identify and recruit top talent in Asia. Since its inception, Wantedlab has raised over $20 million in funding and is actively expanding its presence to major cities worldwide.
ImmunoMet Therapeutics
Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, that develops and commercializes innovative oncology drugs aimed at enhancing the quality of life for cancer patients. Founded in 2015, the company focuses on creating metabolic regulators that target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors designed to modulate anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet is committed to advancing its comprehensive pipeline to address the challenges faced by patients with resistant forms of cancer.
Yanolja
Series B in 2016
Yanolja is a leisure platform headquartered in Seoul, South Korea, that provides a comprehensive range of online accommodation and travel services. Founded in 2005, the company connects various aspects of travel, including lodging, leisure activities, and transportation, allowing users to book diverse hotel options globally. Yanolja leverages advanced technologies such as artificial intelligence, blockchain, and IoT to enhance its offerings. In addition to consumer services, the company provides cloud-based software solutions for hotels, residences, and leisure facilities, streamlining operations and improving efficiency across the travel industry.
InnoSpark
Series B in 2015
InnoSpark Inc. is a mobile game development company based in Seoul, South Korea, founded in 2012. The company focuses on creating traffic-oriented network games that emphasize social interaction. Its portfolio includes combat strategy games and social dragon breeding games, aiming to engage users through innovative gameplay experiences. InnoSpark is dedicated to developing and publishing games that appeal to a global audience.
The News Funnel
Angel Round in 2014
The News Funnel is an online platform designed to aggregate real estate news and public relations content, catering specifically to busy professionals in the industry. By leveraging a sophisticated search engine, the company curates and distributes trade news and insights from reputable media sources and real estate firms. Users can customize their news feeds according to geographic markets, industry segments, and personal interests, ensuring they stay informed about relevant developments. Additionally, The News Funnel allows clients to upload their own company news at no cost, enhancing the platform's utility for real estate professionals seeking to engage with current trends and updates in the market.
ChannelBreeze
Venture Round in 2013
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.
ZigBang
Seed Round in 2011
ZigBang Co., Ltd. is a property listing platform and application based in Seoul, South Korea, which connects real estate agents with renters. Founded in 2010, the company operates a real estate marketplace that facilitates apartment hunting through its mobile and web platforms. Users can search for rental properties based on various criteria, including the number of rooms, occupants, and price. ZigBang has reported a user base of approximately 6 million, providing a comprehensive tool for individuals seeking rental accommodations while aiming to optimize their search and potentially reduce housing costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.